Últimas noticias sobre Azul (NYSE:AZUL) Bolsa

Azul

Azul SA is involved in the operation of regular and non-regular airline passenger services, cargo or mail, passenger charter, provision of maintenance and hangarage services for aircraft, engines, parts and pieces, aircraft acquisition and lease, development of frequent-flyer programs, development of related activities and equity holding in other companies. The Company considers that it has a single reportable segment which is air transport.

Azul S.A. American Depositary Shares (each representing three preferred shares)

Azul SA

Chardan Capital analyst Daniil Gataulin maintains CervoMed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>) with a Buy and maintains $55 price target.

News

Price Target

Analyst Ratings

CRVO

Chardan Capital Maintains Buy on CervoMed, Maintains $55 Price Target

The Company will carefully analyze this expression of interest, decide on next steps, and inform the capital market in accordance with the legal requirements.

HALO

Evotec Confirms Receipt Of Non-binding Expression Of Interest From Halozyme Therapeutics With An Offer Price Of EUR 11.00 Per Share

PEDEVCO (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PED#AMEX">PED</a>) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.01 by 200 percent. The company reported quarterly sales of $9.100 million which beat the analyst consensus estimate of $8.859 million by 2.72 percent. This is a 24.15 percent increase over sales of $7.330 million the same period last year.

Earnings

Earnings Beats

PEDEVCO Q3 2024 GAAP EPS $0.03 Beats $0.01 Estimate, Sales $9.100M Beat $8.859M Estimate

Forte Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBRX#NASDAQ">FBRX</a>) reported quarterly losses of $(4.54) per share which beat the analyst consensus estimate of $(7.12) by 36.24 percent. This is a 30.9 percent increase over losses of $(6.57) per share from the same period last year.

FBRX

Forte Biosciences Q3 EPS $(4.54) Beats $(7.12) Estimate

Jefferies analyst Omar Nokta maintains Safe Bulkers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SB#NYSE">SB</a>) with a Buy and maintains $6 price target.

Jefferies Maintains Buy on Safe Bulkers, Maintains $6 Price Target

Reviva Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 47.92 percent increase over losses of $(0.48) per share from the same period last year.

RVPH

Reviva Pharmaceuticals Q3 2024 GAAP EPS $(0.25) Beats $(0.26) Estimate

Nova Lifestyle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVFY#NASDAQ">NVFY</a>) reported quarterly losses of $(0.72) per share. This is a 13.25 percent increase over losses of $(0.83) per share from the same period last year. The company reported $2.62 million in sales this quarter. This is a 5.65 percent increase over sales of $2.48 million the same period last year.

NVFY

Nova Lifestyle Q3 EPS $(0.72) Up From $(0.83) YoY, Sales $2.62M Up From $2.48M YoY

Hedge Funds

General

FLUT

SPOT

ValueAct Holdings' Q3 2024 13F Filing Reveals Full Exits From Spotify, Fiserv, KKR & Co., New York Times With 1.34M Shares, And Flutter Entertainment

COLL

COLLEGIUM PHARMACEUTICAL Announced That Health Canada Has Approved Its Drug Jornay-PM For The Treatment Of ADHD In Children

Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) shares are trading higher in Thursday&#8217;s after-hours session after the company announced it will transfer its stock listing <a href="https://www.benzinga.com/pressreleases/24/11/b41988795/palantir-announces-transfer-of-stock-exchange-listing-to-nasdaq">to the Nasdaq</a>.
What Happened: After the market close on Thursday, Palantir announced that it would transfer the listing of its Class A common stock from the New York Stock Exchange to the Nasdaq Global Select Market.
Palantir said it expects to begin trading as a Nasdaq-listed company on Nov. 26. The stock will continue to trade under the ticker symbol &#8220;PLTR.&#8221;
&#8220;Upon transferring, Palantir anticipates meeting the eligibility requirements of the Nasdaq-100 Index,&#8221; the company said.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41984278/jim-simons-renaissance-technologies-shifts-gears-microsoft-in-tesla-out-palantir-on-top">Jim Simons&#8217; Renaissance Technologies Shifts Gears: Microsoft In, Tesla Out, Palantir On Top</a>
Palantir has been one of the hottest stocks of the year, having gained approximately 245% year-to-date, driven by the company&#8217;s positioning in the <a href="http://benzinga.com/topic/ai">AI</a> space. 
Palantir shares really took off at the beginning of November after the company reported <a href="https://www.benzinga.com/news/earnings/24/11/41730179/palantir-q3-earnings-revenue-beat-eps-beat-customers-up-39-raises-guidance-results-driven-by-unrele">strong quarterly results</a> driven by&nbsp;"unrelenting" AI demand. 
Revenue jumped 30% year-over-year on continued strength in the U.S. customer count grew 39% year-over-year after the company closed 104 deals worth over $1 million during the quarter.
"The growth of our business is accelerating, and our financial performance is exceeding expectations as we meet an unwavering demand for the most advanced artificial intelligence technologies from our U.S. government and commercial customers,&#8221;&nbsp;Alex Karp, co-founder and CEO of Palantir, said in a letter to shareholders.
PLTR Price Action: Palantir shares were up 3.87% in after-hours, trading at $61.47 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

After-Hours Center

Movers

Tech

PLTR

Palantir Stock Is Rising After The Bell: What's Going On?

Trading Ideas

GOOG

GOOGL

Pershing Square Capital's Q3 2024 13F Filing Reveals Reduced Stakes In Hilton Worldwide By 18% To 7.37M Shares, Chipotle Mexican Grill By 8%, Restaurant Brands Intl By 1% To 23.0M Shares, And Alphabet Class C And Class A By 9%

Pershing Square Capital's Q3 2024 13F Filing Shows New Stakes In Brookfield Corp With 25.88M Shares, Nike With 13.24M Shares, And Seaport Entertainment Group With 2.09M Shares Each In Common Stock And Rights

RBLX

ValueAct Holdings' Q3 2024 13F Filing Indicates Increased Stakes In Walt Disney By 22% To 7.46M Shares And Roblox By 341% To 10.14M Shares

LLYVA

LLYVK

ValueAct Holdings' Q3 2024 13F Filing Shows New Stakes In Meta Platforms With 211.5K Shares, Live Nation Entertainment With 1.01M Shares, Visa With 373.6K Shares, Liberty Media Corp Series C With 1.34M Shares, And Liberty Media Corp Series A With 671.8K Shares

The loss is primarily attributable to a non-cash change in fair value of warrant liabilities related to common share price and warrant price appreciation during the quarter, production restart related operating expenses, and interest expense.

Sable Offshore Reports Q3 Net Income Of $(255.6)M

Marker Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRKR#NASDAQ">MRKR</a>) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.39) by 33.33 percent. The company reported quarterly sales of $1.926 million which beat the analyst consensus estimate of $1.000 million by 92.60 percent. This is a 647.65 percent increase over sales of $257.606 thousand the same period last year.

MRKR

Marker Therapeutics Q3 2024 GAAP EPS $(0.26) Beats $(0.39) Estimate, Sales $1.926M Beat $1.000M Estimate

Telsey Advisory Group analyst Dana Telsey maintains Lulus Fashion Lounge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVLU#NASDAQ">LVLU</a>) with a Market Perform and maintains $2 price target.

LVLU

Telsey Advisory Group Maintains Market Perform on Lulus Fashion Lounge, Maintains $2 Price Target

XWEL

XWELL Q3 Revenue $8.4M Up From $7.5M YoY

NNOX

NVDA

RXRX

Nvidia 13F Shows Decreased Stake In Arm Holdings By 13% From 320,823 To 280,411 Shares; Decreased Stake In Recursion Pharmaceuticals By 12% From 57,797 To 50,784 Shares; Decreased Stake In Nano X Imaging Ltd By 17% From 437 To 362 Shares

Earnings Misses

POET

POET Technologies Q3 2024 GAAP EPS $(0.20) Misses $(0.090) Estimate

Azul S.A. struggling to find investors for debt-for-equity deal - report

Azul SA (AZUL) has released an update. Azul S.A. has secured an agreement for up to $500 million in additional funding from existing bondholders, s...

Azul Secures $500 Million Funding Amid Restructuring

Azul reaches deal with bondholders, creditors for $400M in funding

Latest data shows the largest indicative borrow rate increases among liquid option names include: VinFast Auto LTD (VFS) 146.99% +26.88, Azul (AZUL...

Largest borrow rate increases among liquid names

Azul Q3 2024 Earnings Preview

Here's the major earnings before the open tomorrow

Azul SA (AZUL) has released an update. Azul S.A., Brazil's leading airline, has revised its 2024 outlook with an expected 6% increase in capacity a...

Azul S.A. Updates Financial Projections Amid Market Dynamics

Azul SA (AZUL) has released an update. Azul S.A., Brazil's leading airline, posted record financial results for the third quarter of 2024, with rev...

Azul SA Achieves Record Revenues and Optimizes Balance Sheet

Azul SA (AZUL) has released an update. Azul S.A. has announced a significant financial restructuring plan, securing up to $500 million in new fundi...

Azul S.A. Secures $500 Million for Financial Stability

Azul S.A. (AZUL) Q3 2024 Earnings Call Transcript

AFMD

ANRO

AZUL

BILI

BLUE

BTAI

CASI

CRIS

CVSI

DTEGY

EONGY

GOLLQ

ITRM

KEYUF

KNTNF

LTBR

LUNR

MKGAF

NICE

NLCP

NTES

OCUL

ONEW

PAVM

PDSB

POLA

PVCT

QBTS

SACH

SERV

SIEGY

SPCB

VEON

VISL

WKHS

XNET

Press Releases

Azul Airlines and Silver Airways announce a codeshare agreement for flights between Brazil and the United States

Azul is once again recognized by its Successful Capital Optimization Plan concluded in 2023

Azul TecOps Gains EASA Approval for Maintenance Services of European Union-Registered Aircraft

Azul's technical team is two-time champion in maintenance tournament in the United States

Azul Files Form 20-F Report for the Fiscal Year Ended 2023

Contracts

Azul and GOL Announce Codeshare Agreement

Azul and GOL start selling 40 shared routes across Brazil

Azul Entrusts Viasat to Deliver Advanced In-Flight Connectivity to Airbus A330-900neo Fleet

Azul Celebrates Successful Negotiations with Partners and Announces Strengthened Financial Position

VSAT

American Airlines Group, Inc. - Common Stock

American Airlines Gr

Allegiant Travel

Alaska Air Gr

Blade Air Mobility, Inc. - Class A Common Stock

Blade Air Mobility

Copa Holdings

Delta Air Lines

flyExclusive

JetBlue Airways Corporation - Common Stock

JetBlue Airways

Joby Aviation

Jet AI

LATAM Airlines Group S.A. American Depositary Shares (each representing two thousand (2,000) shares of Common Stock)

LATAM Airlines Group

Southwest Airlines

Mesa Air Gr

Ryanair Holdings plc - American Depositary Shares, each representing five Ordinary Shares

Ryanair Hldgs

Spirit Airlines

SkyWest

Sun Country Airlines Holdings, Inc. - Common Stock

Sun Country Airlines

Volato Group

Surf Air Mobility

United Airlines Holdings, Inc. - Common Stock

United Airlines Holdings

Frontier Group Holdings, Inc. - Common Stock

Frontier Group Holdings

Wheels Up Experience Inc. Class A Common Stock

Wheels Up Experience

Controladora Vuela Compania de Aviacion, S.A.B. de C.V. American Depositary Shares, each representing ten (10) Ordinary Participation Certificates

Comments

Azul

Noticias

Últimas noticias sobre Azul (NYSE:AZUL) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL